Memorial Sloan Kettering Cancer Center (MSK) and MSK Direct State of the Union

At the 2025 MSK Direct Benefits Leaders’ Summit, MSK’s Chief Physician Executive, Dr. Lisa DeAngelis, shares key recognitions in MSK’s research innovations and how MSK is building towards the future. MSK Direct Executive Director, Emily Kauff, highlights that people treated at MSK live better, longer, with new research data showing MSK’s 5-year survival advantage across all cancers among working age adults is higher than the national average. She also shares key figures from 2024 for MSK Direct and where the program’s focus will be in 2025.